Prognostic and Predictive Value of Tumor-infiltrating Leukocytes and of Immune Checkpoint Molecules PD1 and PDL1 in Clear Cell Renal Cell Carcinoma

INTRODUCTION: Immune checkpoint inhibitors (ICI) have been approved for patients with clear cell renal cell carcinoma (ccRCC), but not all patients benefit from ICI. One reason is the tumor microenvironment (TME) that has substantial influence on patient's prognosis and therapy response. Thus,...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Transl Oncol
Asıl Yazarlar: Stenzel, Philipp J., Schindeldecker, Mario, Tagscherer, Katrin E., Foersch, Sebastian, Herpel, Esther, Hohenfellner, Markus, Hatiboglu, Gencay, Alt, Juergen, Thomas, Christian, Haferkamp, Axel, Roth, Wilfried, Macher-Goeppinger, Stephan
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Neoplasia Press 2019
Konular:
Original article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7031108/
https://ncbi.nlm.nih.gov/pubmed/31881506
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2019.11.002
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller